# A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma

Source: https://onco.cc/trials/nct06413498/  
OnCo record `nct06413498` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 3 trial of Anitocabtagene autoleucel, Cyclophosphamide, Fludarabine in multiple myeloma, run by Kite, A Gilead Company, active and no longer recruiting.

## Summary

A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma is a phase 3 interventional study registered as NCT06413498 by Kite, A Gilead Company, with 452 participants enrolled, started 2024-08-23 and due to reach its primary completion in 2028-07. Interventions recorded: Anitocabtagene Autoleucel, Cyclophosphamide, Fludarabine, Pomalidomide, Bortezomib. Conditions listed: Multiple Myeloma. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: active
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06413498
- Phase: 3
- Setting: A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma
- Sponsor: Kite, A Gilead Company
- Enrolled: 452

## Sources

- ClinicalTrials.gov NCT06413498: https://clinicaltrials.gov/study/NCT06413498

## Connected records

- cancers: [Multiple myeloma](https://onco.cc/cancers/multiple-myeloma/)
- drugs: [Anitocabtagene autoleucel](https://onco.cc/drugs/anitocabtagene-autoleucel/), [Bortezomib](https://onco.cc/drugs/bortezomib/), [Cyclophosphamide](https://onco.cc/drugs/cyclophosphamide/), [Dexamethasone](https://onco.cc/drugs/dexamethasone/), [Fludarabine](https://onco.cc/drugs/fludarabine/), [Pomalidomide](https://onco.cc/drugs/pomalidomide/)
- companies: [Gilead Sciences (incl. Kite)](https://onco.cc/companies/gilead/)

---
JSON: https://onco.cc/api/v1/entities/nct06413498.json